Moneta Group Investment Advisors LLC Athersys, Inc Transaction History

Moneta Group Investment Advisors LLC

  • $9.24 Billion
  • Q3 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.18 - $0.86 $187 - $896
1,042 Added 3.51%
30,769 $8,000
Q1 2022

May 11, 2022
SELL
$0.6 - $1.06 $112 - $198
-187 Reduced 0.63%
29,727 $18,000
Q4 2021

Feb 11, 2022
SELL
$0.85 - $1.4 $136 - $225
-161 Reduced 0.54%
29,914 $27,000
Q3 2021

Nov 12, 2021
BUY
$1.33 - $1.77 $284 - $378
214 Added 0.72%
30,075 $40,000
Q2 2021

Aug 13, 2021
SELL
$1.41 - $1.94 $195 - $269
-139 Reduced 0.46%
29,861 $43,000
Q1 2021

May 14, 2021
SELL
$1.61 - $2.77 $460 - $792
-286 Reduced 0.94%
30,000 $54,000
Q4 2020

Feb 12, 2021
BUY
$1.55 - $2.24 $46 - $67
30 Added 0.1%
30,286 $53,000
Q3 2020

Nov 13, 2020
BUY
$1.91 - $3.08 $57,788 - $93,188
30,256 New
30,256 $59,000
Q1 2020

May 13, 2020
SELL
$1.17 - $3.0 $13,316 - $34,146
-11,382 Closed
0 $0
Q4 2019

Feb 11, 2020
BUY
$1.16 - $1.42 $120 - $147
104 Added 0.92%
11,382 $14,000
Q3 2019

Nov 12, 2019
SELL
$1.21 - $1.65 $38 - $52
-32 Reduced 0.28%
11,278 $15,000
Q2 2019

Aug 16, 2019
SELL
$1.39 - $2.03 $11,079 - $16,181
-7,971 Reduced 41.34%
11,310 $19,000
Q2 2019

Aug 13, 2019
BUY
$1.39 - $2.03 $11,047 - $16,134
7,948 Added 70.13%
19,281 $19,000
Q1 2019

May 16, 2019
SELL
$1.39 - $1.71 $25,020 - $30,780
-18,000 Reduced 61.36%
11,333 $17,000
Q1 2019

May 15, 2019
BUY
$1.39 - $1.71 $25,328 - $31,159
18,222 Added 164.0%
29,333 $17,000
Q4 2018

Feb 11, 2019
SELL
$1.41 - $2.16 $28,505 - $43,668
-20,217 Reduced 64.53%
11,111 $16,000
Q3 2018

Nov 13, 2018
BUY
$1.86 - $2.18 $56,162 - $65,825
30,195 Added 2665.05%
31,328 $66,000
Q2 2018

Aug 14, 2018
BUY
$1.76 - $2.79 $1,994 - $3,161
1,133 New
1,133 $2,000

About ATHERSYS, INC

ATHX Quotes by TradingView
  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Moneta Group Investment Advisors LLC Portfolio

Follow Moneta Group Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moneta Group Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moneta Group Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email